We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRYO RNS Number : 4183A Cryo-Save Group NV 08 October 2009 8 October 2009 Cryo-Save Group NV Share Consolidation Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Company"), Europe's leading stem cell bank, confirms that pursuant to the passing of the relevant resolutions at an EGM of the Company held on 5 October 2009, and as notified on that day, the proposed 5:1 share consolidation has this morning become effective. As result of the share consolidation the Company's authorised share capital now comprises 9,639,191 ordinary shares of EUR0.10 each; the associated depository interests for these ordinary shares will commence trading at 8:00am today under ISIN NL0009272137. +------------------------------------+---------------------------------+ | For further details: | | +------------------------------------+---------------------------------+ | | | +------------------------------------+---------------------------------+ | Cryo-Save Group | + 31 (0)575 548998 | +------------------------------------+---------------------------------+ | Marc Waeterschoot, Chief Executive | | | | | +------------------------------------+---------------------------------+ | Arnoud van Tulder, Chief Financial | | | Officer | | +------------------------------------+---------------------------------+ | | | +------------------------------------+---------------------------------+ | Daniel Stewart & Company plc | + 44 (0) 20 7776 6550 | +------------------------------------+---------------------------------+ | Simon Leathers | | +------------------------------------+---------------------------------+ | | | +------------------------------------+---------------------------------+ | College Hill | + 44 (0) 20 7457 2020 | +------------------------------------+---------------------------------+ | Adrian Duffield/Rozi Morris | | +------------------------------------+---------------------------------+ About Cryo-Save With more than 115,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). Cryo-Save sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases in the future. As a service to the public, Cryo-Save offers a Cost-free Family Donation Programme, free of charge, to families wishing to store their newborn's umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treatable by stem cells. The company is committed to further improve stem cell cryopreservation techniques, by participating in European Commission funded projects, in Universities and Hospitals. This information is provided by RNS The company news service from the London Stock Exchange END CARZGMGGKNKGLZM
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions